Table 1.
Method | Scalable | Advantages | Disadvantages |
---|---|---|---|
Magnetic bead isolation | Not currently | Fast; pure product | Costly; low yield; depends on knowledge of specific surface markers; need to remove EVs from antibodies |
Ultrafiltration | Yes | Works with large volumes | Potential losses under high pressure; impure product |
Differential ultracentrifugation | No | Most commonly used method; best to produce large quantities; pure product | Includes contaminants; additional isolation steps necessary; difficult to resuspend the EV pellets |
Density gradient ultracentrifugation | No | Commonly used method; highest purity products | Media components interfere with EV function; volume limitations apply; slow process |
High-performance liquid chromatography (size exclusion) | Yes | Ideal for large scale | Shown to preserve therapeutic activity |
Size-exclusion chromatography | Yes | Good separation, removing albumin, many lipoproteins | Postcolumn concentration may be needed |
Tangential flow filtration; for example, a closed system of AKTATM Flux 6 tangential flow filtration50 | Yes | Ideal for industrial manufacturing; commercially available; can process the samples at a large scale | Need to purchase the device, not readily available for research |
Precipitation or “salting out” | Yes | Does not require specialized equipment; fast PEG precipitation has been used to generate clinical-grade EVs | Relatively impure product; PEG may interfere with some downstream assays and processes |
Asymmetric flow field-flow fractionation49 | Yes | Can isolate the EVs of different sizes | Costly; may not be commercially available yet |
A thermophoretic aptasensor15 | Not currently | Enrich EVs conjugated with Cy5-labeled single-strand DNA aptamers; good for diagnosis | Not good for EV production; costly |
Reiner et al.18
EV, extracellular vesicle; PEG, polyethylene glycol.